Biotherapeutics
October 19, 2026
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
September 24, 2025
December 11, 2024
October 29, 2024
October 25, 2024
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community